{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T20:16:35Z","timestamp":1788034595210,"version":"build-2784847793"},"reference-count":86,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:00:00Z","timestamp":1785801600000},"content-version":"vor","delay-in-days":3,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001352","name":"National University of Singapore","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001352","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","valueinhealthjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Value in Health"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.jval.2026.06.025","type":"journal-article","created":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T15:22:27Z","timestamp":1786029747000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Economic Evaluations of Hypertension Interventions in Pregnancy Lack Standardization: Results of a Systematic Review"],"prefix":"10.1016","author":[{"given":"Ling Jie","family":"Cheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucy","family":"Abel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svetlana","family":"Ratushnyak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Rivero-Arias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard J.","family":"McManus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucy C.","family":"Chappell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen E.","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jval.2026.06.025_bib1","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2022-072157","article-title":"Maternal hypertensive disorder of pregnancy and mortality in offspring from birth to young adulthood: national population based cohort study","volume":"379","author":"Huang","year":"2022","journal-title":"BMJ"},{"issue":"4","key":"10.1016\/j.jval.2026.06.025_bib2","doi-asserted-by":"crossref","first-page":"e626","DOI":"10.1016\/S2214-109X(24)00560-6","article-title":"Global and regional causes of maternal deaths 2009-20: a WHO systematic analysis","volume":"13","author":"Cresswell","year":"2025","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.jval.2026.06.025_bib3","article-title":"Pre-eclampsia: pathophysiology and clinical implications","volume":"366","author":"Burton","year":"2019","journal-title":"BMJ"},{"issue":"9","key":"10.1016\/j.jval.2026.06.025_bib4","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1161\/HYPERTENSIONAHA.123.21061","article-title":"Long-term impacts of preeclampsia on the cardiovascular system of mother and offspring","volume":"80","author":"Yang","year":"2023","journal-title":"Hypertension"},{"issue":"9","key":"10.1016\/j.jval.2026.06.025_bib5","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.3390\/jcm14093121","article-title":"Long-term cardiovascular risk and maternal history of pre-eclampsia","volume":"14","author":"Palmiero","year":"2025","journal-title":"J Clin Med"},{"issue":"1","key":"10.1016\/j.jval.2026.06.025_bib6","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/s41572-023-00417-6","article-title":"Pre-eclampsia","volume":"9","author":"Dimitriadis","year":"2023","journal-title":"Nat Rev Dis Prim"},{"issue":"9","key":"10.1016\/j.jval.2026.06.025_bib7","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-058068","article-title":"Impact of gestational hypertension and pre-eclampsia on preterm birth in China: a large prospective cohort study","volume":"12","author":"An","year":"2022","journal-title":"BMJ Open"},{"issue":"12","key":"10.1016\/j.jval.2026.06.025_bib8","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1111\/1471-0528.14702","article-title":"Outcome reporting across randomised controlled trials evaluating therapeutic interventions for pre-eclampsia","volume":"124","author":"Duffy","year":"2017","journal-title":"BJOG"},{"key":"10.1016\/j.jval.2026.06.025_bib10","author":"Guthrie"},{"key":"10.1016\/j.jval.2026.06.025_bib11","series-title":"National Cost Collection Data Publication: National Schedule 2023\/24","year":"2024"},{"key":"10.1016\/j.jval.2026.06.025_bib12","series-title":"Methods for the Economic Evaluation of Health Care Programmes","author":"Drummond","year":"2005"},{"issue":"6","key":"10.1016\/j.jval.2026.06.025_bib13","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/bioe.12120","article-title":"Valuing stillbirths","volume":"29","author":"Phillips","year":"2015","journal-title":"Bioethics"},{"key":"10.1016\/j.jval.2026.06.025_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2024.102840","article-title":"Global, regional, and national burden of preterm birth, 1990\u20132021: a systematic analysis from the global burden of disease study 2021","volume":"76","author":"Liang","year":"2024","journal-title":"EClinicalmedicine"},{"issue":"6","key":"10.1016\/j.jval.2026.06.025_bib15","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2015-008136","article-title":"Clinical cardiovascular risk during young adulthood in offspring of hypertensive pregnancies: insights from a 20-year prospective follow-up birth cohort","volume":"5","author":"Davis","year":"2015","journal-title":"BMJ Open"},{"issue":"12","key":"10.1016\/j.jval.2026.06.025_bib16","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1016\/j.jval.2022.07.014","article-title":"Economic evaluation of prenatal and postpartum care in women with gestational diabetes and hypertensive disorders of pregnancy: a systematic review","volume":"25","author":"Li","year":"2022","journal-title":"Value Health"},{"issue":"5","key":"10.1016\/j.jval.2026.06.025_bib17","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1136\/archdischild-2018-315778","article-title":"Economic consequences of preterm birth: a systematic review of the recent literature (2009-2017)","volume":"104","author":"Petrou","year":"2019","journal-title":"Arch Dis Child"},{"issue":"10","key":"10.1016\/j.jval.2026.06.025_bib18","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1007\/s40273-015-0291-x","article-title":"Pre-eclampsia diagnosis and treatment options: a review of published economic assessments","volume":"33","author":"Zakiyah","year":"2015","journal-title":"Pharmacoeconomics"},{"issue":"11","key":"10.1016\/j.jval.2026.06.025_bib19","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.44372","article-title":"Economic evaluation of blood pressure monitoring techniques in patients with hypertension: a systematic review","volume":"6","author":"Hayek","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"2","key":"10.1016\/j.jval.2026.06.025_bib20","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.amepre.2021.06.025","article-title":"Systematic review of self-measured blood pressure monitoring with support: intervention effectiveness and cost","volume":"62","author":"Shantharam","year":"2022","journal-title":"Am J Prev Med"},{"issue":"6S2","key":"10.1016\/j.jval.2026.06.025_bib21","doi-asserted-by":"crossref","first-page":"S121","DOI":"10.1016\/j.amepre.2017.05.008","article-title":"A systematic review of economic evidence on community hypertension interventions","volume":"53","author":"Zhang","year":"2017","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.jval.2026.06.025_bib22","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"issue":"4","key":"10.1016\/j.jval.2026.06.025_bib23","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.jval.2021.01.002","article-title":"Critical appraisal of systematic reviews with costs and cost-effectiveness outcomes: an ISPOR good practices task force report","volume":"24","author":"Mandrik","year":"2021","journal-title":"Value Health"},{"issue":"3","key":"10.1016\/j.jval.2026.06.025_bib24","doi-asserted-by":"crossref","first-page":"A12","DOI":"10.7326\/ACPJC-1995-123-3-A12","article-title":"The well-built clinical question: a key to evidence-based decisions","volume":"123","author":"Richardson","year":"1995","journal-title":"ACP J Club"},{"issue":"9","key":"10.1016\/j.jval.2026.06.025_bib25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002389","article-title":"Self-monitoring of blood pressure in hypertension: a systematic review and individual patient data meta-analysis","volume":"14","author":"Tucker","year":"2017","journal-title":"PLOS Med"},{"issue":"1","key":"10.1016\/j.jval.2026.06.025_bib28","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s13643-016-0384-4","article-title":"Rayyan-a web and mobile app for systematic reviews","volume":"5","author":"Ouzzani","year":"2016","journal-title":"Syst Rev"},{"issue":"3","key":"10.1016\/j.jval.2026.06.025_bib29","doi-asserted-by":"crossref","first-page":"276","DOI":"10.11613\/BM.2012.031","article-title":"Interrater reliability: the kappa statistic","volume":"22","author":"McHugh","year":"2012","journal-title":"Biochem Med (Zagreb)"},{"issue":"1","key":"10.1016\/j.jval.2026.06.025_bib30","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jval.2021.11.1351","article-title":"Consolidated health economic evaluation reporting standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations","volume":"25","author":"Husereau","year":"2022","journal-title":"Value Health"},{"issue":"5","key":"10.1016\/j.jval.2026.06.025_bib31","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/j.1524-4733.2005.00045.x","article-title":"Good research practices for cost-effectiveness analysis alongside clinical trials: the ISPOR RCT-CEA Task Force report","volume":"8","author":"Ramsey","year":"2005","journal-title":"Value Health"},{"issue":"36","key":"10.1016\/j.jval.2026.06.025_bib32","doi-asserted-by":"crossref","DOI":"10.3310\/hta8360","article-title":"Review of guidelines for good practice in decision-analytic modelling in health technology assessment","volume":"8","author":"Philips","year":"2004","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.jval.2026.06.025_bib33","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.g6616","article-title":"Is self monitoring of blood pressure in pregnancy safe and effective?","volume":"349","author":"Hodgkinson","year":"2014","journal-title":"BMJ"},{"issue":"7","key":"10.1016\/j.jval.2026.06.025_bib34","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1001\/jamasurg.2021.0540","article-title":"CHEERS reporting guidelines for economic evaluations","volume":"156","author":"Fayanju","year":"2021","journal-title":"JAMA Surg"},{"issue":"4","key":"10.1016\/j.jval.2026.06.025_bib35","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1161\/HYPERTENSIONAHA.116.07466","article-title":"The cost implications of Less Tight versus Tight control of hypertension in pregnancy (CHIPS trial)","volume":"68","author":"Ahmed","year":"2016","journal-title":"Hypertension"},{"issue":"3","key":"10.1016\/j.jval.2026.06.025_bib36","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/1471-0528.13957","article-title":"An economic analysis of immediate delivery and expectant monitoring in women with hypertensive disorders of pregnancy, between 34 and 37 weeks of gestation (HYPITAT-II)","volume":"124","author":"van Baaren","year":"2017","journal-title":"BJOG"},{"key":"10.1016\/j.jval.2026.06.025_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.jri.2023.104141","article-title":"Cost-effectiveness analysis of a first-trimester screening test for preterm preeclampsia in the Netherlands","volume":"160","author":"Beernink","year":"2023","journal-title":"J Reprod Immunol"},{"key":"10.1016\/j.jval.2026.06.025_bib38","first-page":"310","article-title":"The use of magnesium sulfate to prevent seizures in the pre-eclamptic gravida: a cost-effectiveness analysis","volume":"6","author":"Blackwell","year":"2001","journal-title":"Prenat Neonatal Med"},{"issue":"5","key":"10.1016\/j.jval.2026.06.025_bib39","doi-asserted-by":"crossref","first-page":"05","DOI":"10.1136\/bmjgh-2020-004123","article-title":"Economic and cost-effectiveness analysis of the Community-Level Interventions for Pre-eclampsia (CLIP) trials in India, Pakistan and Mozambique","volume":"6","author":"Bone","year":"2021","journal-title":"BMJ Glob Health"},{"issue":"4","key":"10.1016\/j.jval.2026.06.025_bib40","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1161\/HYPERTENSIONAHA.123.22059","article-title":"Detection and control of pregnancy hypertension using self-monitoring of blood pressure with automated telemonitoring: cost analyses of the BUMP randomized trials","volume":"81","author":"Campbell","year":"2024","journal-title":"Hypertension"},{"issue":"4","key":"10.1016\/j.jval.2026.06.025_bib41","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1097\/AOG.0000000000005531","article-title":"Treating mild chronic hypertension during pregnancy: a cost-effectiveness analysis","volume":"143","author":"Doshi","year":"2024","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jval.2026.06.025_bib42","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.preghy.2021.06.012","article-title":"Cost-utility of a first-trimester screening strategy versus the standard of care for nulliparous women to prevent pre-term pre-eclampsia in Belgium","volume":"25","author":"Dubon Garcia","year":"2021","journal-title":"Pregnancy Hypertens"},{"issue":"Suppl 2","key":"10.1016\/j.jval.2026.06.025_bib43","first-page":"179","article-title":"Placental growth factor testing for suspected preeclampsia: a cost-minimisation analysis","volume":"126","author":"Duhig","year":"2019","journal-title":"BJOG"},{"issue":"87","key":"10.1016\/j.jval.2026.06.025_bib44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta20870","article-title":"Placental growth factor (alone or in combination with soluble fms-like tyrosine kinase 1) as an aid to the assessment of women with suspected pre-eclampsia: systematic review and economic analysis","volume":"20","author":"Frampton","year":"2016","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.jval.2026.06.025_bib45","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.preghy.2021.03.004","article-title":"SAFE@HOME: cost analysis of a new care pathway including a digital health platform for women at increased risk of preeclampsia","volume":"24","author":"van den Heuvel","year":"2021","journal-title":"Pregnancy Hypertens"},{"issue":"6","key":"10.1016\/j.jval.2026.06.025_bib46","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1097\/AOG.0000000000005197","article-title":"Association of a remote blood pressure monitoring program with postpartum adverse outcomes","volume":"141","author":"Hirshberg","year":"2023","journal-title":"Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.jval.2026.06.025_bib47","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/s41669-022-00355-1","article-title":"Cost-utility analysis of planned early delivery or expectant management for late preterm pre-eclampsia (Phoenix)","volume":"6","author":"Hunter","year":"2022","journal-title":"Pharmacoeconom Open"},{"issue":"3","key":"10.1016\/j.jval.2026.06.025_bib48","first-page":"6","article-title":"Evaluating the cost-effectiveness of folic acid versus methyltetrahydrofolate in preventing preeclampsia in Makassar, Indonesia","volume":"16","author":"Kamri","year":"2024","journal-title":"Cureus"},{"issue":"8","key":"10.1016\/j.jval.2026.06.025_bib49","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1089\/tmj.2018.0147","article-title":"A prenatal remote monitoring program in pregnancies complicated with gestational hypertensive disorders: what are the contributors to the cost savings?","volume":"25","author":"Lanssens","year":"2019","journal-title":"Telemed J Health"},{"issue":"13","key":"10.1016\/j.jval.2026.06.025_bib50","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1111\/1471-0528.15285","article-title":"Foley catheter vs. oral misoprostol to induce labour among hypertensive women in India: a cost-consequence analysis alongside a clinical trial","volume":"125","author":"Leigh","year":"2018","journal-title":"BJOG"},{"issue":"11","key":"10.1016\/j.jval.2026.06.025_bib51","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1004481","article-title":"Determining optimal timing of birth for women with chronic or gestational hypertension at term: the WILL (When to Induce Labour to Limit risk in pregnancy hypertension) randomised trial","volume":"21","author":"Magee","year":"2024","journal-title":"PLOS Med"},{"key":"10.1016\/j.jval.2026.06.025_bib52","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.deveng.2017.06.002","article-title":"Cost effectiveness of medical devices to diagnose pre-eclampsia in low-resource settings","volume":"2","author":"McLaren","year":"2017","journal-title":"Dev Eng"},{"issue":"6","key":"10.1016\/j.jval.2026.06.025_bib53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta12060","article-title":"Methods of prediction and prevention of pre-eclampsia: systematic reviews of accuracy and effectiveness literature with economic modelling","volume":"12","author":"Meads","year":"2008","journal-title":"Health Technol Assess"},{"issue":"6","key":"10.1016\/j.jval.2026.06.025_bib54","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0270490","article-title":"Cost-effectiveness analysis of implementing screening on preterm pre-eclampsia at first trimester of pregnancy in Germany and Switzerland","volume":"17","author":"Mewes","year":"2022","journal-title":"PLOS One"},{"issue":"6","key":"10.1016\/j.jval.2026.06.025_bib55","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1161\/HYPERTENSIONAHA.118.11718","article-title":"Preeclampsia prevention using routine versus screening test-indicated aspirin in low-risk women","volume":"72","author":"Mone","year":"2018","journal-title":"Hypertension"},{"issue":"2","key":"10.1016\/j.jval.2026.06.025_bib56","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/1471-0528.17598","article-title":"First trimester screening for pre-eclampsia and targeted aspirin prophylaxis: a cost-effectiveness cohort study","volume":"131","author":"Nzelu","year":"2024","journal-title":"BJOG"},{"issue":"7","key":"10.1016\/j.jval.2026.06.025_bib57","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/s41440-021-00624-2","article-title":"Economic evaluation of the sFlt-1\/PlGF ratio for the short-term prediction of preeclampsia in a Japanese cohort of the PROGNOSIS Asia study","volume":"44","author":"Ohkuchi","year":"2021","journal-title":"Hypertens Res"},{"issue":"5","key":"10.1016\/j.jval.2026.06.025_bib58","first-page":"1","article-title":"First-trimester screening program for the risk of pre-eclampsia using a multiple-marker algorithm: a health technology assessment","volume":"22","year":"2023","journal-title":"Ont Health Technol Assess Ser"},{"issue":"2","key":"10.1016\/j.jval.2026.06.025_bib59","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/uog.19076","article-title":"Cost-effectiveness of first-trimester screening with early preventative use of aspirin in women at high risk of early-onset pre-eclampsia","volume":"53","author":"Ortved","year":"2019","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.jval.2026.06.025_bib60","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1002\/uog.22193","article-title":"Cost-effectiveness analysis of a model of first-trimester prediction and prevention of preterm pre-eclampsia compared with usual care","volume":"58","author":"Park","year":"2021","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.jval.2026.06.025_bib61","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/pd.2871","article-title":"Economic assessment of screening for pre-eclampsia","volume":"32","author":"Shmueli","year":"2012","journal-title":"Prenat Diagn"},{"issue":"2","key":"10.1016\/j.jval.2026.06.025_bib62","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/j.1471-0528.2005.00785.x","article-title":"Magpie Trial Collaborative. Cost-effectiveness of prophylactic magnesium sulphate for 9996 women with pre-eclampsia from 33 countries: economic evaluation of the magpie Trial","volume":"113","author":"Simon","year":"2006","journal-title":"BJOG"},{"issue":"7","key":"10.1016\/j.jval.2026.06.025_bib63","article-title":"Which first-trimester risk assessment method for preeclampsia is most suitable? A model-based impact study","volume":"5","author":"Strijbos","year":"2023","journal-title":"Am J Obstet Gynecol MFM"},{"issue":"6","key":"10.1016\/j.jval.2026.06.025_bib64","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/j.1471-0528.1992.tb13781.x","article-title":"An economic evaluation of daycare in the management of hypertension in pregnancy","volume":"99","author":"Twaddle","year":"1992","journal-title":"BJOG"},{"issue":"13","key":"10.1016\/j.jval.2026.06.025_bib65","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1111\/j.1471-0528.2010.02710.x","article-title":"An economic analysis of induction of labour and expectant monitoring in women with gestational hypertension or pre-eclampsia at term (HYPITAT trial)","volume":"117","author":"Vijgen","year":"2010","journal-title":"BJOG"},{"issue":"61","key":"10.1016\/j.jval.2026.06.025_bib66","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta21610","article-title":"Spot protein\u2014creatinine ratio and spot albumin\u2014creatinine ratio in the assessment of pre-eclampsia: a diagnostic accuracy study with decision-analytic model-based economic evaluation and acceptability analysis","volume":"21","author":"Waugh","year":"2017","journal-title":"Health Technol Assess"},{"issue":"6","key":"10.1016\/j.jval.2026.06.025_bib67","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1097\/AOG.0000000000001115","article-title":"A cost-benefit analysis of low-dose aspirin prophylaxis for the prevention of preeclampsia in the United States","volume":"126","author":"Werner","year":"2015","journal-title":"Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.jval.2026.06.025_bib68","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1002\/uog.19041","article-title":"Home blood-pressure monitoring in a hypertensive pregnant population: cost-minimization study","volume":"53","author":"Xydopoulos","year":"2019","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.jval.2026.06.025_bib69","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0267313","article-title":"Early cost-effectiveness analysis of screening for preeclampsia in nulliparous women: a modelling approach in European high-income settings","volume":"17","author":"Zakiyah","year":"2022","journal-title":"PLOS One"},{"issue":"1","key":"10.1016\/j.jval.2026.06.025_bib70","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s12955-024-02293-4","article-title":"How are maternal and fetal outcomes incorporated when measuring benefits of interventions in pregnancy? Findings from a systematic review of cost-utility analyses","volume":"22","author":"Abel","year":"2024","journal-title":"Health Qual Life Outcomes"},{"issue":"4","key":"10.1016\/j.jval.2026.06.025_bib71","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1046\/j.1523-536X.2003.0251a.x","article-title":"Preference-based approaches to measuring the benefits of perinatal care","volume":"30","author":"Petrou","year":"2003","journal-title":"Birth"},{"issue":"4","key":"10.1016\/j.jval.2026.06.025_bib72","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1002\/hec.1375","article-title":"The valuation of prenatal life in economic evaluations of perinatal interventions","volume":"18","author":"Simon","year":"2009","journal-title":"Health Econ"},{"issue":"5","key":"10.1016\/j.jval.2026.06.025_bib73","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s40273-020-00884-9","article-title":"Feasibility, validity and differences in adolescent and adult EQ-5D-Y health state valuation in Australia and Spain: an application of best-worst scaling","volume":"38","author":"Dalziel","year":"2020","journal-title":"Pharmacoeconomics"},{"issue":"4","key":"10.1016\/j.jval.2026.06.025_bib74","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1002\/hec.3165","article-title":"Nothing about us without us? A comparison of adolescent and adult health-state values for the child health Utility-9D using profile case best-worst scaling","volume":"25","author":"Ratcliffe","year":"2016","journal-title":"Health Econ"},{"issue":"4","key":"10.1016\/j.jval.2026.06.025_bib75","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s40273-019-00873-7","article-title":"Review of valuation methods of preference-based measures of health for economic evaluation in child and adolescent populations: where are we now and where are we going?","volume":"38","author":"Rowen","year":"2020","journal-title":"Pharmacoeconomics"},{"issue":"7","key":"10.1016\/j.jval.2026.06.025_bib76","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.jval.2020.02.011","article-title":"A review of the methods used to generate utility values in NICE technology assessments for children and adolescents","volume":"23","author":"Hill","year":"2020","journal-title":"Value Health"},{"issue":"52","key":"10.1016\/j.jval.2026.06.025_bib77","doi-asserted-by":"crossref","DOI":"10.3310\/hta11520","article-title":"A review and critique of modelling in prioritising and designing screening programmes","volume":"11","author":"Karnon","year":"2007","journal-title":"Health Technol Assess"},{"issue":"8","key":"10.1016\/j.jval.2026.06.025_bib78","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-048031","article-title":"Methods for evaluating the benefits and harms of antenatal and newborn screening programmes adopted by health economic assessments: protocol for a systematic review","volume":"11","author":"Png","year":"2021","journal-title":"BMJ Open"},{"key":"10.1016\/j.jval.2026.06.025_bib79","author":"Devlin"},{"issue":"7","key":"10.1016\/j.jval.2026.06.025_bib80","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/s40273-025-01493-0","article-title":"How do health state values differ when respondents consider adults versus children living in those states? A systematic review","volume":"43","author":"De Silva","year":"2025","journal-title":"Pharmacoeconomics"},{"issue":"9778","key":"10.1016\/j.jval.2026.06.025_bib81","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1016\/S0140-6736(11)60279-1","article-title":"Counting stillbirths: women\u2019s health and reproductive rights","volume":"377","author":"Kelley","year":"2011","journal-title":"Lancet"},{"issue":"27","key":"10.1016\/j.jval.2026.06.025_bib82","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta14270","article-title":"Weighting and valuing quality-adjusted life-years using stated preference methods: preliminary results from the Social Value of a QALY Project","volume":"14","author":"Baker","year":"2010","journal-title":"Health Technol Assess"},{"issue":"7627","key":"10.1016\/j.jval.2026.06.025_bib83","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1136\/bmj.39335.385301.BE","article-title":"Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis","volume":"335","author":"Bellamy","year":"2007","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.jval.2026.06.025_bib84","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.preghy.2011.08.116","article-title":"Hypertensive disorders of pregnancy and future health and mortality: a record linkage study","volume":"2","author":"Bhattacharya","year":"2012","journal-title":"Pregnancy Hypertens"},{"issue":"5","key":"10.1016\/j.jval.2026.06.025_bib85","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.ahj.2008.06.042","article-title":"Cardiovascular sequelae of preeclampsia\/eclampsia: a systematic review and meta-analyses","volume":"156","author":"McDonald","year":"2008","journal-title":"Am Heart J"},{"issue":"9273","key":"10.1016\/j.jval.2026.06.025_bib86","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1016\/S0140-6736(00)05112-6","article-title":"Pregnancy complications and maternal risk of ischaemic heart disease: a retrospective cohort study of 129,290 births","volume":"357","author":"Smith","year":"2001","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.jval.2026.06.025_bib87","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1093\/ehjqcco\/qcaf011","article-title":"Economic burden of cardiovascular disease in the United Kingdom","volume":"11","author":"Shih","year":"2025","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"issue":"5","key":"10.1016\/j.jval.2026.06.025_bib88","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1111\/ppe.12906","article-title":"Economic costs and health utility values associated with extremely preterm birth: evidence from the EPICure2 cohort study","volume":"36","author":"Achana","year":"2022","journal-title":"Paediatr Perinat Epidemiol"},{"issue":"12","key":"10.1016\/j.jval.2026.06.025_bib89","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1111\/1471-0528.16319","article-title":"A core outcome set for pre-eclampsia research: an international consensus development study","volume":"127","author":"Duffy","year":"2020","journal-title":"BJOG"}],"container-title":["Value in Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098301526025696?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098301526025696?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T19:28:27Z","timestamp":1788031707000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1098301526025696"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":86,"alternative-id":["S1098301526025696"],"URL":"https:\/\/doi.org\/10.1016\/j.jval.2026.06.025","relation":{},"ISSN":["1098-3015"],"issn-type":[{"value":"1098-3015","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Economic Evaluations of Hypertension Interventions in Pregnancy Lack Standardization: Results of a Systematic Review","name":"articletitle","label":"Article Title"},{"value":"Value in Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jval.2026.06.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 International Society for Pharmacoeconomics and Outcomes Research, Inc. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}